You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • FRI0267 A Prediction Model That Identifies Patients Most Likely to Benefit from First-Line Therapy with Adalimumab plus Methotrexate in Early Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - anti-TNF therapy
FRI0267 A Prediction Model That Identifies Patients Most Likely to Benefit from First-Line Therapy with Adalimumab plus Methotrexate in Early Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: June 2014 to January 2024

AbstractFullPdf
Jun 2014500
Jul 2014100
Aug 2014300
Sep 2014100
Oct 2014402
Nov 2014700
Dec 2014601
Jan 2015300
Feb 2015500
Mar 2015802
Apr 2015400
Jun 2015200
Jul 2015601
Aug 2015200
Sep 2015300
Oct 2015101
Nov 2015102
Feb 2016301
Mar 2016200
Apr 2016500
May 2016700
Jun 2016301
Jul 2016500
Aug 2016500
Sep 2016600
Oct 2016400
Nov 2016600
Dec 2016501
Jan 2017601
Feb 20171000
Mar 2017700
Apr 2017500
May 20171307
Jul 2017400
Aug 2017800
Sep 2017400
Oct 2017200
Nov 2017400
Dec 20171200
Jan 2018800
Mar 2018800
Apr 2018800
May 20185001
Jun 2018800
Jul 2018600
Aug 2018600
Sep 20182002
Oct 2018600
Nov 2018200
Dec 2018200
Jan 2019200
Feb 2019400
Mar 2019100
Apr 2019400
May 2019200
Jun 2019200
Aug 2019601
Sep 20191000
Jan 2020800
Feb 2020201
Jun 2020200
Jul 2020800
Aug 2020200
Sep 20201001
Oct 2020400
Nov 2020200
Dec 2020200
Jan 2021200
Oct 2021002
Nov 2021800
Dec 2021800
Feb 2022600
Mar 2022200
Apr 2022200
May 2022200
Jul 20221200
Aug 2022600
Sep 2022200
Oct 2022200
Nov 2022800
Dec 2022600
Jan 2023400
Feb 2023400
Mar 2023200
May 2023400
Jun 20231203
Jul 2023200
Sep 2023400
Dec 2023600
Jan 2024200
Total489031